Cited by 110Psychosomatic Disorders and Their TreatmentsLong-Term Effects of COVID-19Fibromyalgia and Chronic Fatigue Syndrome Research

Which neurological diseases are most likely to be associated with “symptoms unexplained by organic disease”

Stone, J., Carson, A., Duncan, R., Roberts, R., Coleman, R., Warlow, C., Murray, G., Pelosi, A. +4 more·2012·Journal of Neurology

Abstract

Many patients with a diagnosis of neurological disease, such as multiple sclerosis, have symptoms or disability that is considered to be in excess of what would be expected from that disease. We aimed to describe the overall and relative frequency of symptoms 'unexplained by organic disease' in patients attending general neurology clinics with a range of neurological disease diagnoses. Newly referred outpatients attending neurology clinics in all the NHS neurological centres in Scotland, UK were recruited over a period of 15 months. The assessing neurologists recorded their initial neurological diagnoses and also the degree to which they considered the patient's symptoms to be explained by organic disease. Patients completed self report scales for both physical and psychological symptoms. The frequency of symptoms unexplained by organic disease was determined for each category of neurological disease diagnoses. 3,781 patients participated (91% of those eligible). 2,467 patients had a diagnosis of a neurological disease (excluding headache disorders). 293 patients (12%) of these patients were rated as having symptoms only "somewhat" or "not at all" explained by that disease. These patients self-reported more physical and more psychological symptoms than those with more explained symptoms. No category of neurological disease was more likely than the others to be associated with such symptoms although patients with epilepsy had fewer. A substantial proportion of new outpatients…

Integrity signals

Registry

Crossref · 10.1007/s00415-011-6111-0

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a 2011 study of new neurology outpatients, 32 out of 252 (13%) patients with MS were rated by the neurologist as having symptoms only "somewhat" or "not at all" explained by MS.

    “In a 2011 study of new neurology outpatients with a diagnosis of neurological disease, 32 out of 252 (13%) patients with MS were rated by the neurologist as having symptoms only “somewhat” or “not at all” explained by that disease [33].”
  • In the Scottish Neurological Symptoms Study (SNSS), 9 out of 209 (4%) patients with a diagnosis of MS or demyelination at baseline had an alternative diagnosis at 18 months follow-up, of whom three (33%) had a functional disorder or psychiatric diagnosis at follow-up (anxiety and chronic fatigue syndrome).

    “In the Scottish Neurological Symptoms Study (SNSS), 9 out of 209 (4%) patients with a diagnosis of MS or demyelination [33] at baseline had an alternative diagnosis at 18 months follow-up, of whom three (33%) had a functional disorder or psychiatric diagnosis at follow-up (anxiety and chronic fatigue syndrome) [34].”

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 24 · Cited by 110

Authors
Stone, J., Carson, A., Duncan, R., Roberts, R., Coleman, R., Warlow, C., Murray, G., Pelosi, A., Cavanagh, J., Matthews, K., Goldbeck, R., & Sharpe, M.
Affiliations
  • University of Edinburgh (GB)
  • Southern General Hospital (GB)
  • University of Dundee (GB)
  • Aberdeen Royal Infirmary (GB)
  • Hairmyres Hospital (GB)
  • University of Glasgow (GB)
Corresponding author
Stone, J.
Venue
Journal of Neurology
Published
2011-06-16
Volume
259
Issue
1
Pages
33-38
ISSN
  • 0012-1037 (ISSN-L)
  • 0340-5354
  • 1432-1459
OpenAlex
W2012176677
Cited by
110
References
24
Citations by year
2026: 4 · 2025: 8 · 2024: 12 · 2023: 9 · 2022: 17 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 7 · 2014: 6 · 2013: 5 · 2012: 1
FWCI
2.63
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
Keywords
neurological disorders, multiple sclerosis, epilepsy, somatic symptoms, psychological symptoms, disability, neurology outpatients
MeSH terms
Adult, Aged, Anxiety, Conversion Disorder, Depression, Emotions, Epilepsy, Female, Humans, Male, Middle Aged, Nervous System Diseases, Neurologic Examination, Pain, Scotland, Somatoform Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review